1-8 of 8
Donata Rimoldi
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Vaccination with LAG-3Ig (IMP321) and Peptides Induces Specific CD4 and CD8 T-Cell Responses in Metastatic Melanoma Patients—Report of a Phase I/IIa Clinical Trial

Free
Amandine Legat, Hélène Maby-El Hajjami, Petra Baumgaertner, Laurène Cagnon, Samia Abed Maillard, Christine Geldhof, Emanuela M. Iancu, Luc Lebon, Philippe Guillaume, Danijel Dojcinovic, Olivier Michielin, Emanuela Romano, Grégoire Berthod, Donata Rimoldi, Frédéric Triebel, Immanuel Luescher, Nathalie Rufer, Daniel E. Speiser
Journal: Clinical Cancer Research
Clin Cancer Res (2016) 22 (6): 1330–1340.
https://doi.org/10.1158/1078-0432.CCR-15-1212
Published: 14 March 2016
View articletitled, Vaccination with LAG-3Ig (IMP321) and Peptides Induces Specific CD4 and CD8 T-Cell Responses in Metastatic Melanoma Patients—Report of a Phase I/IIa Clinical Trial
Open the PDF for Vaccination with LAG-3Ig (IMP321) and Peptides Induces Specific CD4 and CD8 T-Cell Responses in Metastatic Melanoma Patients—Report of a Phase I/IIa Clinical Trial in another window
Includes: Supplementary data
Journal Articles

Identification of Multiple Mechanisms of Resistance to Vemurafenib in a Patient with BRAFV600E-Mutated Cutaneous Melanoma Successfully Rechallenged after Progression

Free
Emanuela Romano, Sylvain Pradervand, Alexandra Paillusson, Johann Weber, Keith Harshman, Katja Muehlethaler, Daniel Speiser, Solange Peters, Donata Rimoldi, Olivier Michielin
Journal: Clinical Cancer Research
Clin Cancer Res (2013) 19 (20): 5749–5757.
https://doi.org/10.1158/1078-0432.CCR-13-0661
Published: 14 October 2013
View articletitled, Identification of Multiple Mechanisms of Resistance to Vemurafenib in a Patient with BRAFV600E-Mutated Cutaneous Melanoma Successfully Rechallenged after Progression
Open the PDF for Identification of Multiple Mechanisms of Resistance to Vemurafenib in a Patient with BRAFV600E-Mutated Cutaneous Melanoma Successfully Rechallenged after Progression in another window
Includes: Supplementary data
Journal Articles

Toll-like Receptor 3 Expressed by Melanoma Cells as a Target for Therapy?

Free
Bruno Salaun, Serge Lebecque, Sampsa Matikainen, Donata Rimoldi, Pedro Romero
Journal: Clinical Cancer Research
Clin Cancer Res (2007) 13 (15): 4565–4574.
https://doi.org/10.1158/1078-0432.CCR-07-0274
Published: 01 August 2007
View articletitled, Toll-like Receptor 3 Expressed by Melanoma Cells as a Target for Therapy?
Open the PDF for Toll-like Receptor 3 Expressed by Melanoma Cells as a Target for Therapy? in another window
Journal Articles

Long-Term Protective Effect of Mature DC-LAMP+ Dendritic Cell Accumulation in Sentinel Lymph Nodes Containing Micrometastatic Melanoma

Free
Bruce Elliott, Richard A. Scolyer, Stefan Suciu, Serge Lebecque, Donata Rimoldi, Oliver Gugerli, Elena Musat, Raghwa N. Sharma, Danielle Lienard, Ulrich Keilholz, Alessandro Testori, Alexander Eggermont, Rona MacKie, Caroline Robert, Martin Cook, John F. Thompson, Eric Angevin, Alain Spatz, on behalf of the European Organization for Research and Treatment of Cancer Melanoma Group
Journal: Clinical Cancer Research
Clin Cancer Res (2007) 13 (13): 3825–3830.
https://doi.org/10.1158/1078-0432.CCR-07-0358
Published: 02 July 2007
View articletitled, Long-Term Protective Effect of Mature DC-LAMP+ Dendritic Cell Accumulation in Sentinel Lymph Nodes Containing Micrometastatic Melanoma
Open the PDF for Long-Term Protective Effect of Mature DC-LAMP+ Dendritic Cell Accumulation in Sentinel Lymph Nodes Containing Micrometastatic Melanoma in another window
Journal Articles

Expression of the Apoptosis Inhibitor Protease Inhibitor 9 Predicts Clinical Outcome in Vaccinated Patients with Stage III and IV Melanoma

Free
Inge S. van Houdt, Joost J. Oudejans, Alfonsus J.M. van den Eertwegh, Arnold Baars, Wim Vos, Bellinda A. Bladergroen, Donata Rimoldi, Jettie J.F. Muris, Erik Hooijberg, Chad M. Gundy, Chris J.L.M. Meijer, Jean A. Kummer
Journal: Clinical Cancer Research
Clin Cancer Res (2005) 11 (17): 6400–6407.
https://doi.org/10.1158/1078-0432.CCR-05-0306
Published: 06 September 2005
View articletitled, Expression of the Apoptosis Inhibitor Protease Inhibitor 9 Predicts Clinical Outcome in Vaccinated Patients with Stage III and IV Melanoma
Open the PDF for Expression of the Apoptosis Inhibitor Protease Inhibitor 9 Predicts Clinical Outcome in Vaccinated Patients with Stage III and IV Melanoma in another window
Journal Articles

Activation of Human Melanoma Reactive CD8+ T Cells by Vaccination with an Immunogenic Peptide Analog Derived from Melan-A/Melanoma Antigen Recognized by T Cells-1

Free
Maha Ayyoub, Alfred Zippelius, Mikaël J. Pittet, Donata Rimoldi, Danila Valmori, Jean-Charles Cerottini, Pedro Romero, Ferdy Lejeune, Danielle Liénard, Daniel E. Speiser
Journal: Clinical Cancer Research
Clin Cancer Res (2003) 9 (2): 669–677.
Published: 01 February 2003
View articletitled, Activation of Human Melanoma Reactive CD8+ T Cells by Vaccination with an Immunogenic Peptide Analog Derived from Melan-A/Melanoma Antigen Recognized by T Cells-1
Open the PDF for Activation of Human Melanoma Reactive CD8+ T Cells by Vaccination with an Immunogenic Peptide Analog Derived from Melan-A/Melanoma Antigen Recognized by T Cells-1 in another window
Journal Articles

Expansion and Functional Maturation of Human Tumor Antigen-specific CD8+ T Cells after Vaccination with Antigenic Peptide

Free
Mikaël J. Pittet, Daniel E. Speiser, Danielle Liénard, Danila Valmori, Philippe Guillaume, Valérie Dutoit, Donata Rimoldi, Ferdy Lejeune, Jean-Charles Cerottini, Pedro Romero
Journal: Clinical Cancer Research
Clin Cancer Res (2001) 7 (3): 796s–803s.
Published: 01 March 2001
View articletitled, Expansion and Functional Maturation of Human Tumor Antigen-specific CD8+ T Cells after Vaccination with Antigenic Peptide
Open the PDF for Expansion and Functional Maturation of Human Tumor Antigen-specific CD8+ T Cells after Vaccination with Antigenic Peptide in another window
Journal Articles

CD8+ T-Cell Response to NY-ESO-1: Relative Antigenicity and in Vitro Immunogenicity of Natural and Analogue Sequences

Free
Pedro Romero, Valerie Dutoit, Verena Rubio-Godoy, Danielle Liénard, Daniel Speiser, Philippe Guillaume, Katerina Servis, Donata Rimoldi, Jean-Charles Cerottini, Danila Valmori
Journal: Clinical Cancer Research
Clin Cancer Res (2001) 7 (3): 766s–772s.
Published: 01 March 2001
View articletitled, CD8+ T-Cell Response to NY-ESO-1: Relative Antigenicity and in Vitro Immunogenicity of Natural and Analogue Sequences
Open the PDF for CD8+ T-Cell Response to NY-ESO-1: Relative Antigenicity and in Vitro Immunogenicity of Natural and Analogue Sequences in another window